SpiceJet announced that Ajay will invest INR 294.99 crores in the airline via Spice Healthcare Private Limited. This will be done through the conversion of 13,14 crore warrants to a similar number equity shares.

After this transaction the Promoter Group’s stake in SpiceJet increases from 29,11 to 33.47 per cent, which is a significant improvement in their position in the airline.

SpiceJet must continue to invest in its growth and financial security. Capital injection is a key part of this effort. Ajay’s move will see him dispose of up to 3,15 crore shares. Spice Healthcare Private Limited can use the proceeds of the sale of these equity shares to contribute the remaining 75 % at the time the equity shares are allocated. This shows the Promoter Group’s confidence in the future of the airline.

SpiceJet’s financial stability and operational capability will be improved by the new injection of funds. SpiceJet has repeatedly proven its resilience in the face of challenges. This latest injection further underscores Promoter Group’s faith in the airline’s ability to continue on its growth and recovery trajectory.

By March 18, 2025 a meeting of either the Board of Directors, or the Board Committee, will be held in order to approve the allocation of shares of equity for the conversion process. Investors and stakeholders expect this decision to increase confidence in SpiceJet.

Ajay Sing commented, “This fresh injection reaffirms commitment to the carrier, and its brighter faiuture. This investment will strengthen the financial position of SpiceJet and drive growth. SpiceJet has a strong and resilient airline. With this new capital we will be in a position to enhance our operation and take advantage new opportunities.”

SpiceJet has achieved another important milestone through the successful conversion and capital infusion of warrants. This move reflects Promoter Group’s belief that the airline will emerge stronger and more competitive within the aviation sector.